Section of Pediatric and Congenital Cardiac Surgery, Department of Surgery, Morgan Stanley Children's Hospital of New York-Presbyterian, Columbia University, New York, NY.
Department of Pediatric Cardiac Surgery, Marie Lannelongue Hospital, Paris, France.
J Thorac Cardiovasc Surg. 2018 Jul;156(1):278-286. doi: 10.1016/j.jtcvs.2018.02.038. Epub 2018 Feb 23.
The optimal management and prognostic factors of postsurgical pulmonary vein stenosis remain controversial. We sought to determine current postsurgical pulmonary vein stenosis outcomes and prognostic factors in a multicentric study in the current era.
Seventy-five patients with postsurgical pulmonary vein stenosis who underwent 103 procedures in 14 European/North American centers (2000-2012) were included retrospectively. A specific pulmonary vein stenosis severity score was developed on the basis of the assessment of each pulmonary vein. End points were death, pulmonary vein reintervention, and restenosis. A univariate and multivariate risk analysis was performed.
Some 76% of postsurgical pulmonary vein stenosis occurred after repair of a total anomalous pulmonary venous return. Sutureless repair was used in 42 of 103 procedures (41%), patch veinoplasty was used in 28 procedures (27%), and endarterectomy was used in 16 procedures (16%). Overall pulmonary vein restenosis, reintervention, and mortality occurred in 56% (n = 58/103), 49% (n = 50/103), and 27% (n = 20/75), respectively. Sutureless repair was associated with less restenosis (40% vs 67%; P = .007) and less reintervention (31% vs 61%; P = .003). Mortality after sutureless repair (20%; 7/35) tends to be lower than after nonsutureless repair (33%; 13/40) (P = .22). A high postoperative residual pulmonary vein stenosis score at the time of hospital discharge was an independent risk factor for restenosis (hazard ratio [HR], 1.55; P < 10), reintervention (HR, 1.33; P < 10), and mortality (HR, 1.37; P < 10). The sutureless technique was an independent protective factor against restenosis (HR, 0.27; P = .006).
Postsurgical pulmonary vein stenosis still has a guarded prognosis in the current era. The sutureless technique is an independent protective factor against restenosis. The severity of the residual disease evaluated by a new severity score is an independent risk factor for poor outcomes regardless of surgical technique.
术后肺静脉狭窄的最佳治疗方法和预后因素仍存在争议。我们旨在当前时代,通过一项多中心研究来确定术后肺静脉狭窄的治疗结果和预后因素。
回顾性纳入 14 个欧洲/北美中心的 75 例术后肺静脉狭窄患者(2000-2012 年),共行 103 次手术。基于对每根肺静脉的评估,制定了一种特定的肺静脉狭窄严重程度评分。终点为死亡、肺静脉再介入和再狭窄。进行了单变量和多变量风险分析。
大约 76%的术后肺静脉狭窄发生在完全性肺静脉异位引流修复后。103 次手术中有 42 次(41%)采用无缝线修复,28 次(27%)采用静脉补片成形术,16 次(16%)采用内膜切除术。整体肺静脉再狭窄、再介入和死亡率分别为 56%(n=58/103)、49%(n=50/103)和 27%(n=20/75)。无缝线修复与较低的再狭窄(40%比 67%;P=0.007)和再介入(31%比 61%;P=0.003)相关。无缝线修复后死亡率(20%,7/35)低于非无缝线修复后死亡率(33%,13/40)(P=0.22)。出院时术后残留肺静脉狭窄评分较高是再狭窄(风险比[HR],1.55;P<10)、再介入(HR,1.33;P<10)和死亡率(HR,1.37;P<10)的独立危险因素。无缝线技术是再狭窄的独立保护因素(HR,0.27;P=0.006)。
在当前时代,术后肺静脉狭窄的预后仍不容乐观。无缝线技术是再狭窄的独立保护因素。无论手术技术如何,新严重程度评分评估的残留疾病严重程度都是不良结局的独立危险因素。